Clinical trial
Clinical Trial Assessing Toxicity and Efficacy of MF101 for Hot Flashes
NCT00119665 · Bionovo, Industry · Completed
Key facts
| NCT number | NCT00119665 |
|---|---|
| Title | Clinical Trial Assessing Toxicity and Efficacy of MF101 for Hot Flashes |
| Official title | A Phase II, Double-Blind, Placebo-Controlled, Randomized Clinical Trial Assessing Toxicity and Efficacy of MF101 for Hot Flashes and Menopausal Symptoms |
| Lead sponsor | Bionovo, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hot Flashes |
| Intervention type | Drug |
| Interventions | MF101 |
| Enrollment | 180 |
| Start date | Feb 1, 2006 |
| Completion | Feb 1, 2007 |
| First posted | Jul 14, 2005 |
| Last update posted | May 17, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: